Role of serotonin drugs in the treatment of social phobia

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 5, 1997, Pages 50-54

  Tancer, Manuel E ^a,b   Uhde, Thomas W ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BUSPIRONE; CLONAZEPAM; CLONIDINE; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE MALEATE; LEVODOPA; ONDANSETRON; PAROXETINE; PHENELZINE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY NEUROSIS; DRUG EFFECT; DRUG EFFICACY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SOCIAL PHOBIA; TREATMENT INDICATION;

BUSPIRONE; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FLUVOXAMINE; HUMANS; ONDANSETRON; PHOBIC DISORDERS; PLACEBOS; SEROTONIN AGENTS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0030969186     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Kessler RG, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19
2. Stein MB, Tancer ME, Gelernter CS, et al. Major depression in patients with social phobia. Am J Psychiatry 1990;147:637-639
3. Schneier FR, Martin LY, Liebowitz MR, et al. Alcohol abuse in social phobia. J Anxiety Disord 1989;3:15-23
4. Schneier FR, Johnson J, Hornig CD, et al. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 1992;49:282-288
5. Tancer ME, Uhde TW. Social phobia: a review of pharmacological treatment. CNS Drugs 1995;3:267-278
6. Potts NLS, Davidson JRT. Pharmacological treatments: literature review. In: Heimberg RG, Liebowitz MR, Hope DA, et al, eds. Social Phobia: Diagnosis, Assessment, and Treatment. New York, NY: Guilford Press; 1995: 334-365
7. Gelernter CS, Uhde TW, Cimbolic P, et al. Pharmacotherapy versus cognitive therapy for the treatment of social phobia. Arch Gen Psychiatry 1991; 48:938-945
8. Liebowitz MR, Schneier F, Campeas R, et al. Phenelzine vs atenolol in social phobia: a placebo-controlled comparison. Arch Gen Psychiatry 1992; 49:290-300
9. Versiani M, Nardi AE, Mundim FD, et al. Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 1992;160:353-360
10. Tancer ME, Lewis MH, Stein MB. Biological aspects. In: Stein MB, ed. Social Phobia. Washington, DC: American Psychiatric Press; 1995:229-257
11. Nickell PV, Uhde TW. Neurobiology of social phobia. In: Heimberg RG, Liebowitz MR, Hope DA, et al, eds. Social Phobia: Diagnosis, Assessment, and Treatment. New York, NY: Guilford Press; 1995:113-133
12. Papp LA, Gorman JM, Liebowitz MR, et al. Epinephrine infusions in patients with social phobia. Am J Psychiatry 1988;145:733-736
13. Tancer ME, Stein MB, Uhde TW. Growth hormone response to clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers. Biol Psychiatry 1993;34:591-595
14. Liebowitz MR, Campeas R, Hollander E. MAOIs: impact on social behavior. Psychiatry Res 1987;22:89-90
15. Stein MB, Heuser IJ, Juncos JL, et al. Anxiety disorders in patients with Parkinson's disease. Am J Psychiatry 1990;147:207-210
16. Tancer ME, Mailman RB, Stein MB, et al. Neuroendocrine responsivity to monaminergic system probes in generalized social phobia. Anxiety 1994/ 1995;1:216-223
17. Bagdy G, Calogero AE, Murphy DL, et al. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamic-pituitary-adrenocortical axis in conscious rats. Endocrinology 1989; 125:2664-2669
18. Kahn RS, Asnis GM, Wetzer S, et al. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology (Berl) 1988;96:360-364
19. Targum SD. Differential responses to anxiogenic challenge studies in patients with major depression and panic disorder. Biol Psychiatry 1990; 28:21-34
20. van Vliet IM, den Boer JA, Westenberg HGM. Psychopharmacological treatment of social phobia: a double-blind placebo controlled study with fluvoxamine. Psychopharmacology (Berl) 1994;115:128-134
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Press; 1987
22. Katzelnick DJ, Kobak KA, Greist JH, et al. Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995; 152:1368-1371
23. Schneier FR, Chin SJ, Hollander E, et al. Fluoxetine in social phobia. J Clin Psychopharmacol 1992;12:62-64
24. Black B, Uhde TW, Tancer ME. Fluoxetine for the treatment of social phobia. J Clin Psychopharmacol 1992;12:293-295
25. Van Ameringen M, Mancini C, Streiner DL. Fluoxetine efficacy in social phobia. J Clin Psychiatry 1993;54:27-32
26. Koponen HJ, Lepola UM, Juhani LEV. Fluoxetine in social phobia: a pilot study. Presented at the 15th National Conference of the Anxiety Disorders Association of America; April 7, 1995; Pittsburgh, Pa
27. Van Ameringen M, Mancini C, Streiner D. Sertraline in social phobia. J Affect Disord 1994;31:141-145
28. Martins EA, Pigott TA, Bernstein SE, et al. Sertraline in the treatment of patients with social phobia. Anxiety 1994/1995;1:291-297
29. Czepowicz VD, Johnson MR, Lydiard RB, et al. Sertraline in social phobia. J Clin Psychopharmacol 1995;15:372-373
30. Mancini C, Van Ameringen M, Wilson C. Paroxetine in social phobia: a pilot study. Presented at the 15th National Conference of the Anxiety Disorders Association of America; April 7, 1995; Pittsburgh, Pa
31. DeVane CL, Ware MR, Emmanual NP, et al. The evaluation of the safety, efficacy, and physiological effects of fluvoxamine in social phobia. Presented at the 34th Annual Meeting of the American College of Neuropsychopharmacology; Dec 11-15, 1995; San Juan, Puerto Rico
32. Clark DB, Agras WS. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry 1991;148:598-605
33. Munjack DJ, Bruns J, Baltazar PL, et al. A pilot study of buspirone in the treatment of social phobia. J Anxiety Disord 1991;5:87-98
34. Schneier FR, Saoud JB, Campeas R, et al. Buspirone in social phobia. J Clin Psychopharmacol 1993;13:251-256
35. 3 antagonist, ondansetron in social phobia. Presented at the 33rd Annual Meeting of the American College of Neuropsychopharmacology; Dec 12-16, 1994; San Juan, Puerto Rico
36. Davidson JRT, Potts N, Richichi E, et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13:423-428
37. Heimberg RG, Juster HR, Hope DA, et al. Cognitive-behavioral group treatment: description, case presentation, and empirical support. In: Stein MB, ed. Social Phobia. Washington, DC: American Psychiatric Press; 1995:293-321
38. Hope DA, Holt CS, Heimberg RG. Social phobia. In: Giles TR, ed. Handbook of Effective Psychotherapy. New York, NY: Plenum Press; 1993: 227-251
39. Uhde TW, Tancer ME. Social phobia. In: Beitman B, Klerman G, eds. Integrating Pharmacotherapy and Psychotherapy. Washington, DC: American Psychiatric Press; 1991:231-252